Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells. (Q39332149)

PubMed publication ID

22693251

11 September 2017

title

Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

author name string

Xiaoli Du

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Xiaolan Qian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Alex Papageorge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Aaron J Schetter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

William C Vass

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Xi Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Richard Braverman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Ana I Robles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

Douglas R Lowy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

12 June 2012

1 reference

PubMed publication ID

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

page(s)

4405-4416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities

13 May 2020

cites work

1 reference

12 December 2020

DLC-1: a Rho GTPase-activating protein and tumour suppressor

1 reference

12 December 2020

A PLCdelta1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization

1 reference

12 December 2020

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

1 reference

12 December 2020

Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.

1 reference

12 December 2020

Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage

1 reference

12 December 2020

Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function

1 reference

12 December 2020

The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration

1 reference

12 December 2020

Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf

1 reference

12 December 2020

Give lipids a START: the StAR-related lipid transfer (START) domain in mammals.

1 reference

12 December 2020

Molecular machinery for non-vesicular trafficking of ceramide

1 reference

12 December 2020

StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein.

1 reference

12 December 2020

Caveolin-1 in tumor progression: the good, the bad and the ugly.

1 reference

12 December 2020

Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver

1 reference

12 December 2020

Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway

1 reference

12 December 2020

Elevated expression of caveolin is associated with prostate and breast cancer.

1 reference

12 December 2020

p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities

1 reference

12 December 2020

Rho GTPase function in tumorigenesis

1 reference

12 December 2020

Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer

1 reference

12 December 2020

Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma

1 reference

12 December 2020

Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma.

1 reference

12 December 2020

Caveolin-deficient mice: insights into caveolar function human disease

1 reference

12 December 2020

Efficient intracellular assembly of papillomaviral vectors

1 reference

12 December 2020

Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.

1 reference

12 December 2020

Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function

1 reference

12 December 2020

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

1 reference

12 December 2020

Caveolin-1 expression is associated with high-grade bladder cancer

1 reference

12 December 2020

Rho GTPases: functions and association with cancer

1 reference

12 December 2020

Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP

1 reference

12 December 2020

Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients

1 reference

12 December 2020

Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth.

1 reference

12 December 2020

Interacting proteins dictate function of the minimal START domain phosphatidylcholine transfer protein/StarD2

1 reference

12 December 2020

Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus

1 reference

12 December 2020

Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC

1 reference

12 December 2020

Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility

1 reference

12 December 2020

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1

1 reference

12 December 2020

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression

1 reference

12 December 2020

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

1 reference

12 December 2020

Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung

1 reference

12 December 2020

The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis

1 reference

12 December 2020

The mammalian START domain protein family in lipid transport in health and disease

1 reference

12 December 2020

StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria

1 reference

12 December 2020

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

1 reference

12 December 2020

Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis

1 reference

12 December 2020

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

1 reference

12 December 2020

The 'invisible hand': regulation of RHO GTPases by RHOGDIs

1 reference

12 December 2020

Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells

1 reference

12 December 2020

Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding

1 reference

12 December 2020

DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism

1 reference

12 December 2020

Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)

1 reference

12 December 2020

10.1158/0008-5472.CAN-12-0777

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6264793&resulttype=core&format=json

13 May 2020

PubMed publication ID

22693251

1 reference